BRPI0820868A2 - composto de tiofeno fórmula(i), composição farmacêutica contendo o mesmo e uso deste para a prevenção ou tratamento de doenças ou disturbíos associados a um sistema imune ativado - Google Patents

composto de tiofeno fórmula(i), composição farmacêutica contendo o mesmo e uso deste para a prevenção ou tratamento de doenças ou disturbíos associados a um sistema imune ativado

Info

Publication number: BRPI0820868A2
Authority: BR; Brazil
Prior art keywords: diseases; prevention; treatment; pharmaceutical composition; composition containing
Prior art date: 2007-12-10

Application number

BRPI0820868A

Other languages

English (en)

Inventor

Steiner Beat

Marthys Boris

Mueller Claus

Lescop Cyrille

Bolli Martin

Nayler Oliver

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-10

Filing date

2008-12-09

Publication date

2019-09-24

2008-12-09 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2019-09-24 Publication of BRPI0820868A2 publication Critical patent/BRPI0820868A2/pt

Links

208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000035475 disorder Diseases 0.000 title 1
210000000987 immune system Anatomy 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
230000002265 prevention Effects 0.000 title 1
229930192474 thiophene Natural products 0.000 title 1
-1 thiophene compound Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0820868A 2007-12-10 2008-12-09 composto de tiofeno fórmula(i), composição farmacêutica contendo o mesmo e uso deste para a prevenção ou tratamento de doenças ou disturbíos associados a um sistema imune ativado BRPI0820868A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2007054991		2007-12-10
PCT/IB2008/055156 WO2009074950A2 (en)	2007-12-10	2008-12-09	Thiophene derivatives as agonists of s1p1/edg1

Publications (1)

Publication Number	Publication Date
BRPI0820868A2 true BRPI0820868A2 (pt)	2019-09-24

Family

ID=40640372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820868A BRPI0820868A2 (pt)	2007-12-10	2008-12-09	composto de tiofeno fórmula(i), composição farmacêutica contendo o mesmo e uso deste para a prevenção ou tratamento de doenças ou disturbíos associados a um sistema imune ativado

Country Status (15)

Country	Link
US (1)	US8148410B2 (pt)
EP (1)	EP2222667B1 (pt)
JP (1)	JP5503551B2 (pt)
KR (1)	KR20100095593A (pt)
CN (1)	CN101896482B (pt)
AU (1)	AU2008334297A1 (pt)
BR (1)	BRPI0820868A2 (pt)
CA (1)	CA2706834A1 (pt)
ES (1)	ES2403209T3 (pt)
IL (1)	IL206221A0 (pt)
MA (1)	MA31953B1 (pt)
MX (1)	MX2010005889A (pt)
RU (1)	RU2010128006A (pt)
TW (1)	TW200930363A (pt)
WO (1)	WO2009074950A2 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI404706B (zh) *	2006-01-11	2013-08-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
TWI408139B (zh) *	2006-09-07	2013-09-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
AU2007292993B2 (en) *	2006-09-07	2013-01-24	Idorsia Pharmaceuticals Ltd	Pyridin-4-yl derivatives as immunomodulating agents
MX2009002234A (es) *	2006-09-08	2009-03-16	Actelion Pharmaceuticals Ltd	Derivados de piridin-3-il como agentes inmunomoduladores.
NZ580454A (en) *	2007-03-16	2011-05-27	Actelion Pharmaceuticals Ltd	Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
JP5411877B2 (ja) *	2008-03-06	2014-02-12	アクテリオンファーマシューティカルズリミテッド	ピリジン化合物
CN102015695B (zh) *	2008-03-07	2014-08-27	埃科特莱茵药品有限公司	吡啶-2-基衍生物
JP5481395B2 (ja) *	2008-03-07	2014-04-23	アクテリオンファーマシューティカルズリミテッド	新規なアミノメチルベンゼン誘導体
SI2454255T1 (sl)	2009-07-16	2014-01-31	Actelion Pharmaceuticals Ltd.	Derivati piridin-4-ila kot agonisti s1p1/edg1
EP2560969B1 (en)	2010-04-23	2015-08-12	Bristol-Myers Squibb Company	4-(5-isoxazolyl or 5-pyrrazolyl-1,2,4-oxadiazol-3-yl)-mandelic acid amides as sphingosin-1-phosphate 1 receptor agonists
WO2012040532A1 (en)	2010-09-24	2012-03-29	Bristol-Myers Squibb Company	Substituted oxadiazole compounds and their use as s1p1 agonists
KR101869120B1 (ko)	2011-01-19	2018-06-19	이도르시아 파마슈티컬스 리미티드	2-메톡시-피리딘-4-일 유도체
US9000016B2 (en) *	2012-11-05	2015-04-07	Allergan, Inc.	1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators
ES2770348T3 (es)	2015-05-20	2020-07-01	Idorsia Pharmaceuticals Ltd	Forma cristalina del compuesto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi}-propano-1,2-diol
WO2017076757A1 (en)	2015-11-02	2017-05-11	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
EP3165094A1 (en)	2015-11-03	2017-05-10	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
US20180317490A1 (en)	2015-11-04	2018-11-08	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
US20180354921A1 (en)	2015-11-13	2018-12-13	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
WO2017081310A1 (en)	2015-11-13	2017-05-18	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
CN108289449A (zh)	2015-11-19	2018-07-17	巴斯夫欧洲公司	用于防除植物病原性真菌的取代噁二唑
CN108347937A (zh)	2015-11-19	2018-07-31	巴斯夫欧洲公司	用于防除植物病原性真菌的取代噁二唑
US10986839B2 (en)	2016-04-11	2021-04-27	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
WO2017211650A1 (en)	2016-06-09	2017-12-14	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
WO2017211652A1 (en)	2016-06-09	2017-12-14	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
US20190322631A1 (en)	2016-12-19	2019-10-24	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
EP3339297A1 (en)	2016-12-20	2018-06-27	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
WO2018153730A1 (en)	2017-02-21	2018-08-30	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
EP3606912A1 (en)	2017-04-07	2020-02-12	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
WO2018188962A1 (en)	2017-04-11	2018-10-18	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
WO2018202491A1 (en)	2017-05-04	2018-11-08	Basf Se	Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
WO2018219797A1 (en)	2017-06-02	2018-12-06	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
US20200190043A1 (en)	2017-06-19	2020-06-18	Basf Se	2-[[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]aryloxy](thio)acetamides for combating phytopathogenic fungi
WO2019002158A1 (en)	2017-06-30	2019-01-03	Basf Se	SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI
WO2019025250A1 (en)	2017-08-04	2019-02-07	Basf Se	SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI
WO2019038042A1 (en)	2017-08-21	2019-02-28	Basf Se	SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR THE CONTROL OF PHYTOPATHOGENIC FUNGI
EP3684761A1 (en)	2017-09-18	2020-07-29	Basf Se	Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
WO2019101511A1 (en)	2017-11-23	2019-05-31	Basf Se	Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi
US11014897B1 (en)	2018-10-16	2021-05-25	Celgene Corporation	Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US11186556B1 (en)	2018-10-16	2021-11-30	Celgene Corporation	Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
US11014940B1 (en)	2018-10-16	2021-05-25	Celgene Corporation	Thiazolidinone and oxazolidinone compounds and formulations
US11013723B1 (en)	2018-10-16	2021-05-25	Celgene Corporation	Solid forms of a thiazolidinone compound, compositions and methods of use thereof
WO2025201332A1 (zh) *	2024-03-26	2025-10-02	勤浩医药（苏州）有限公司	噁二唑化合物、包含其的药物组合物及其用途
CN120309605B (zh) *	2025-06-12	2025-09-02	长江大学	一种苯并噁嗪-Tioxazafen衍生物及其制备方法和应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1092929B (de)	1959-04-16	1960-11-17	Hoechst Ag	Verfahren zur Herstellung von substituierten Thiophen-2-carbonsaeureestern bzw. den freien Carbonsaeuren
AU7686891A (en)	1990-04-05	1991-10-30	American National Red Cross, The	A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
CN1223648A (zh) *	1996-07-01	1999-07-21	山之内制药株式会社	新颖的噻吩衍生物及其医药组合物
TW414795B (en) *	1996-07-01	2000-12-11	Yamanouchi Pharma Co Ltd	A thiophene derivative and the pharmaceutical composition
EP1070080A4 (en)	1998-03-09	2004-12-29	Smithkline Beecham Corp	HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND THEIR APPLICATIONS
EP1172361A4 (en) *	1999-04-19	2002-05-08	Shionogi & Co	SULFONAMIDE DERIVATIVES HAVING OXADIAZOLE CORES
JP3974781B2 (ja) *	2000-04-21	2007-09-12	塩野義製薬株式会社	抗癌作用を有するオキサジアゾール誘導体
AU2001248765A1 (en) *	2000-04-21	2001-11-12	Shionogi And Co., Ltd.	Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders
ATE441654T1 (de)	2002-01-18	2009-09-15	Merck & Co Inc	Edg-rezeptoragonisten
AU2003202994B2 (en)	2002-01-18	2007-11-22	Merck Sharp & Dohme Corp.	N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
AU2003279915A1 (en)	2002-10-15	2004-05-04	Merck And Co., Inc.	Process for making azetidine-3-carboxylic acid
AU2004277947A1 (en) *	2003-10-01	2005-04-14	Merck & Co., Inc.	3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
CN1894225A (zh)	2003-12-17	2007-01-10	默克公司	作为鞘氨醇1－磷酸(内皮分化基因)受体激动剂的(3,4－二取代)丙酸酯
WO2006010379A1 (en) *	2004-07-29	2006-02-02	Actelion Pharmaceuticals Ltd.	Novel thiophene derivatives as immunosuppressive agents
WO2006047195A2 (en)	2004-10-22	2006-05-04	Merck & Co., Inc.	2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
WO2006100631A1 (en) *	2005-03-23	2006-09-28	Actelion Pharmaceuticals Ltd	Hydrogenated benzo (c) thiophene derivatives as immunomodulators
DE602006003642D1 (en) *	2005-03-23	2008-12-24	Actelion Pharmaceuticals Ltd	Neue thiophen-derivate als sphingosin-1-phosphat-1-rezeptorantagonisten
ES2370791T3 (es) *	2005-03-23	2011-12-22	Actelion Pharmaceuticals Ltd.	Nuevos derivados de tiofeno como agonistas del receptor de esfingosina-1-fosfato-1.
EP1873153B1 (en) *	2005-04-22	2010-07-07	Daiichi Sankyo Company, Limited	3-azetidinecarboxylic acid derivatives for use as immunosuppressants
EP1881979B1 (en)	2005-04-26	2010-08-11	NeuroSearch A/S	Novel oxadiazole derivatives and their medical use
EP1893591A1 (en)	2005-06-08	2008-03-05	Novartis AG	POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
CA2612661A1 (en) *	2005-06-24	2006-12-28	Actelion Pharmaceuticals Ltd.	Novel thiophene derivatives
WO2007001973A1 (en)	2005-06-28	2007-01-04	Astrazeneca Ab	New use
AR057894A1 (es) *	2005-11-23	2007-12-26	Actelion Pharmaceuticals Ltd	Derivados de tiofeno
TWI404706B (zh) *	2006-01-11	2013-08-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
CN101370805B (zh) *	2006-01-24	2011-04-27	埃科特莱茵药品有限公司	吡啶衍生物
GB0601744D0 (en)	2006-01-27	2006-03-08	Novartis Ag	Organic compounds
JP2009269819A (ja) *	2006-08-25	2009-11-19	Asahi Kasei Pharma Kk	アミン化合物
TWI408139B (zh) *	2006-09-07	2013-09-11	Actelion Pharmaceuticals Ltd	新穎噻吩衍生物
JP2008120794A (ja)	2006-10-16	2008-05-29	Daiichi Sankyo Co Ltd	ヘテロ環化合物を含有する医薬組成物
CN101562977A (zh)	2006-12-15	2009-10-21	艾博特公司	新的二唑化合物
WO2008091967A1 (en)	2007-01-26	2008-07-31	Smithkline Beecham Corporation	Chemical compounds
AU2009258242B2 (en)	2008-05-14	2015-07-16	The Scripps Research Institute	Novel modulators of sphingosine phosphate receptors

2008
- 2008-12-09 KR KR1020107013025A patent/KR20100095593A/ko not_active Withdrawn
- 2008-12-09 BR BRPI0820868A patent/BRPI0820868A2/pt not_active IP Right Cessation
- 2008-12-09 AU AU2008334297A patent/AU2008334297A1/en not_active Abandoned
- 2008-12-09 WO PCT/IB2008/055156 patent/WO2009074950A2/en not_active Ceased
- 2008-12-09 RU RU2010128006/04A patent/RU2010128006A/ru not_active Application Discontinuation
- 2008-12-09 US US12/747,280 patent/US8148410B2/en not_active Expired - Fee Related
- 2008-12-09 EP EP08859227A patent/EP2222667B1/en not_active Not-in-force
- 2008-12-09 CA CA2706834A patent/CA2706834A1/en not_active Abandoned
- 2008-12-09 ES ES08859227T patent/ES2403209T3/es active Active
- 2008-12-09 TW TW097147938A patent/TW200930363A/zh unknown
- 2008-12-09 MX MX2010005889A patent/MX2010005889A/es unknown
- 2008-12-09 CN CN2008801206875A patent/CN101896482B/zh not_active Expired - Fee Related
- 2008-12-09 JP JP2010537572A patent/JP5503551B2/ja not_active Expired - Fee Related
2010
- 2010-06-07 IL IL206221A patent/IL206221A0/en unknown
- 2010-06-30 MA MA32972A patent/MA31953B1/fr unknown

Also Published As

Publication number	Publication date
KR20100095593A (ko)	2010-08-31
JP2011506423A (ja)	2011-03-03
EP2222667A2 (en)	2010-09-01
CA2706834A1 (en)	2009-06-18
IL206221A0 (en)	2010-12-30
MA31953B1 (fr)	2010-12-01
TW200930363A (en)	2009-07-16
US8148410B2 (en)	2012-04-03
ES2403209T3 (es)	2013-05-16
CN101896482B (zh)	2013-01-09
RU2010128006A (ru)	2012-01-20
US20100261702A1 (en)	2010-10-14
AU2008334297A1 (en)	2009-06-18
MX2010005889A (es)	2010-06-22
CN101896482A (zh)	2010-11-24
EP2222667B1 (en)	2013-02-20
WO2009074950A3 (en)	2009-08-06
WO2009074950A2 (en)	2009-06-18
JP5503551B2 (ja)	2014-05-28

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0820868A2 (pt)	2019-09-24	composto de tiofeno fórmula(i), composição farmacêutica contendo o mesmo e uso deste para a prevenção ou tratamento de doenças ou disturbíos associados a um sistema imune ativado
CL2007003352A1 (es)	2008-07-04	Compuestos derivados de heteromonociclos de nitrogeno; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades circulatorias, enfermedades metabolicas y/o enfermedades del sistema nervioso cen
CL2007002641A1 (es)	2008-06-20	Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
CL2007002920A1 (es)	2008-06-06	Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
BR112012000422A2 (pt)	2017-05-09	composto, composição farmacêutica, uso de um composto, e, método para a prevenir tratar ou melhorar doenças do sistema imune
CL2007002594A1 (es)	2008-06-06	Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. .
CL2007003495A1 (es)	2008-05-30	Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer.
LT2878297T (lt)	2020-07-10	Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
BRPI1009252A2 (pt)	2016-03-15	composto, pró-droga, composição farmacêutica, métodos para prevenir ou tratar doenças do sistema nervoso central, e mal de alzheimer, e, uso do composto ou de uma pró-droga do mesmo
BRPI0811262A2 (pt)	2014-11-04	Composto, composto ou sal do mesmo, composição farmacêutica, modulador de receptor de glicocorticóide, método para prevenção e/ou tratamento de bistúrbios metabólicos, doenças inflamatórias, doenças auto-imunes, doenças alérgicas, doenças do sistema nervoso central, doenças cardiovasculares, doenças relacionadas com homeostase ou glaucoma, e uso de pelo menos um composto ou um sal do mesmo
BRPI0817028A2 (pt)	2019-09-24	composto inibidor de diacilglicerol acil tranferase, composição farmacêutica que o contém, uso do composto, métodos para o tratamento ou profilaxia de diabetes, obesidade, distúrbios de alimentação e dislidemias e diabetes do tipo ii
DK1984357T3 (da)	2014-01-13	2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
CL2007002974A1 (es)	2008-05-23	Compuestos derivados de benzoimidazol; composicion farmaceutica; y uso para el tratamiento de trastornos asociados con dgat1.
BRPI1013763A2 (pt)	2015-08-25	Composto ou sal do mesmo, prodroga, composição farmacêutica, agente diminuidor da proteína de ligação de retinol 4, agente para a profilaxia ou tratamento de diabetes, e, uso de um composto
BRPI0816881A2 (pt)	2015-03-17	Composto, composição farmacêutica, uso de um composto, e, métodos para tratar doenças ou distúrbios e para preparar um composto.
BR112012028707A2 (pt)	2019-09-24	composto de glucagon da superfamília de peptídeos exibindo atividade do receptor g com proteína acoplada, pró farmaco, dímero ou multímro, composição farmacêutica que o compreendem e método de administração do mesmo.
BRPI0818615A2 (pt)	2015-04-07	Sistema de aspiração para remoção de líquido descarregado pelo corpo humano, e sensor de líquido para o mesmo.
BRPI0720637A2 (pt)	2014-04-15	Composto ou um sal farmaceuticamente aceitável, uma forma estereoisomérica, tautomérica ou polimórfica do mesmo, métodos para o tratamento de um hospedeiro e de tratamento de infecção, composição farmacêutica, e, uso do composto
CL2007003244A1 (es)	2008-04-04	Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2007003520A1 (es)	2008-08-22	Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
CL2007001778A1 (es)	2008-05-23	Compuestos derivados de 2-pirazinacarboxamida, antagonistas/agonistas inversos selectivos de cb1; proceso de preparacion; composiciones farmaceuticas; y uso para el tratamiento y/o profilaxis de trastornos de ingestion de comida, diabetes tipo ii y a
BRPI0819582A2 (pt)	2015-05-05	"sistema de tratamento de líquido"
BRPI0917138A2 (pt)	2015-11-17	composto, métodos para tratar doenças alérgicas e outras condições inflamatórias, rinite alérgica, e para tratar ou prevenir doença, composição farmacêutica, uso de um composto, e, combinação.
CL2007001630A1 (es)	2008-02-08	Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
BRPI0809346A2 (pt)	2014-10-07	Compostos derivados substituídos de imidazopiridina e composição farmacêutica contendo os mesmos